Medical 3D tech startup Anymedi eyes 2022 Kosdaq IPO

Anymedi Solution Co., South Korea's medical metaverse startup, has applied for a preliminary review of its initial public offering on the junior Kosdaq market, according to investment banking sources on Thursday.

Its IPO manager NH Investment & Securities Co. recently submitted the IPO application to the Korea Exchange to make a trading debut in the first half of next year. 

The company, based on three-dimensional (3D) scanning technology, was established in December 2016, after spun off from Asan Medical Center, the country's largest hospital chain.

Anymedi offers customized surgical planning to reduce the failure rate of operations, applying visual reality, augmented reality and robotics.

It boasts 3D surgery simulators for more than 200 cases ranging from cancer surgery to cosmetic procedures, as well as about 400 surgical guides. Surgeons can perform image-guided surgery using 3D displays.

The startup also develops facial prosthetics made of metals and silicons. Last year, it launched the "innofit" brand to produce customized artificial noses, while running the "innofit lab," a virtual operating room for preoperative planning to ensure more accurate surgical implementation.

As medical schools are increasingly embracing the metaverse for clinical and surgical training, as well as in operating rooms, Anymedi could enjoy rising demand as a metaverse platform.

In 2019, it raised 5.5 billion won ($47 million) in series B funding, two years after its 1.5 billion won fundraising in series A funding. Last year, it reported an operating loss of 3.5 billion won on sales of 132 million won.

Write to Jin-seong Kim at jskim1028@hankyung.com
Yeonhee Kim edited this article.